Evidence map›Paper›PMID 32572177›Full record

ReviewCancer gene therapy2021

LIPG: an inflammation and cancer modulator.

Chang Hong, Ruxia Deng, Ping Wang, Xiansheng Lu, Xin Zhao, Xiaoyu Wang, Rui Cai, Jie Lin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cancer gene therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chang HongThe First Clinical Medical School (Nanfang Hospital), Southern Medical University, Guangzhou, 510515, PR China.ORCID http://orcid.org/0000-0001-5467-7226
Ruxia DengDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, PR China.
Ping WangDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, PR China.
Xiansheng LuDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, PR China.
Xin ZhaoThe First Clinical Medical School (Nanfang Hospital), Southern Medical University, Guangzhou, 510515, PR China.
Xiaoyu WangDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, PR China.
Rui CaiDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, PR China.
Jie LinDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, PR China. jielin_gz@126.com.ORCID http://orcid.org/0000-0002-5952-2319
Southern Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial lipase (LIPG/EL) performs fundamental and vital roles in the human body, including cell composition, cytokine expression, and energy provision. Since LIPG predominantly functions as a phospholipase as well as presents low levels of triglyceride lipase activity, it plays an essential role in lipoprotein metabolism, and involves in the metabolic syndromes such as inflammatory response and atherosclerosis. Cytokines significantly affect LIPG expression in endothelial cells in many diseases. Recently, it is suggested that LIPG contributes to cancer initiation and progression, and LIPG attached increasing importance to its potential for future targeted therapy.

Indexed as

HumansInflammationLipaseNeoplasmsLipaseLIPG protein, human

Identifiers

PMID32572177
OpenAlexW3036668602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.